<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thirty-five patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> were retrospectively classified according to the FAB classification (French-American-British Cooperative Study Group) </plain></SENT>
<SENT sid="1" pm="."><plain>Their prognosis was found to be dependent mainly on the presence of blasts in bone marrow examination </plain></SENT>
<SENT sid="2" pm="."><plain>Those with an excess of blasts in their bone marrow had a median survival of 30 months in contrast to 66 months in those without blasts </plain></SENT>
<SENT sid="3" pm="."><plain>These results were compared with those of seven recent reported series </plain></SENT>
</text></document>